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Abstract
Cryptococcus neoformans and C. gattii are pathogenic basidiomycetous yeasts and the
commonest cause of fungal infection of the central nervous system. Cryptococci are typi-
cally haploid but several inter-species, inter-varietal and intra-varietal hybrids have been
reported. It has a bipolar mating system with sexual reproduction occurring normally
between two individuals with opposite mating types, α and a. This study set out to charac-
terize hybrid isolates within the C. neoformans/C. gattii species complex: seven unisexual
mating intra-varietal VNI/VNII (αAAα) and six novel inter-varietal VNII/VNIV (aADα). The
URA5-RFLP pattern for VNII/VNIV (aADα) differs from the VNIII (αADa) hybrids. Analysis
of the allelic patterns of selected genes for AD hybrids showed 79% or more heterozygosis
for the studied loci except for CBS132 (VNIII), which showed 50% of heterozygosity.
MALDI-TOF MS was applied to hybrids belonging to different sero/mating type allelic pat-
terns. All hybrid isolates were identified as belonging to the same hybrid group with identifi-
cation scores ranging between 2.101 to 2.634. All hybrids were virulent when tested in the
Galleria mellonella (wax moth) model, except for VNII/VNIV (aADα) hybrids. VNI/VGII
hybrids were the most virulent hybrids. Hybrids recovered from larvae manifested a signifi-
cant increase in capsule and total cell size and produced a low proportion (5–10%) of giant
cells compared with the haploid control strains. All strains expressed the major virulence
factors—capsule, melanin and phospholipase B—and grew well at 37˚C. The minimal
inhibitory concentration of nine drugs was measured by micro-broth dilution and compared
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with published data on haploid strains. MICs were similar amongst hybrids and haploid
parental strains. This is the first study reporting natural same sex αAAα intra-varietal VNI/
VNII hybrids and aADα inter-varietal VNII/VNIV hybrids.
Introduction
The basidiomycetous yeasts Cryptococcus neoformans and Cryptococcus gattii are important
human pathogens infectingmainly immunocompromised and immunocompetent individuals,
respectively [1, 2]. For the purpose of this study the traditional two species and 8 molecular
type classification is used [3]. C. neoformans is comprised of two varieties:C. neoformans var.
grubii (serotype A; molecular types VNI and VNII) and C. neoformans var. neoformans (sero-
type D; molecular type VNIV) [4]. In addition, serotype AD hybrids (molecular type VNIII)
which are either diploid or aneuploid, have been reported in clinical and environmental sam-
ples [4–12]. Multi-locus sequence typing (MLST) identified in addition a newmolecular type
(VNB) of serotype A, which was isolated in Botswana [13], Brazil [14], and Italy [15]. The sib-
ling speciesC. gattii has four widely accepted molecular types (VGI, VGII, VGIII, VGIV) dis-
tributed amongst two serotypes (B and C) [4, 16]. Three inter-species hybrid strains were
subsequently reported; two BD hybrids (C. neoformans var. neoformans VNIV × C. gattii
VGI), fromHIV-negative patients in the Netherlands and one AB hybrid (C. neoformans var.
grubii VNI × C. gattii VGI), from an HIV-positive patient in Canada [17, 18]. More recently,
three AB hybrids (C. neoformans var. grubii VNI × C. gattii VGII) fromHIV-negative patients
in Brazil and Colombia and one AB hybrid (C. neoformans var. grubii VNI × C. gattii VGI)
from an HIV-positive patient in India have been described [19].
C. neoformans is typically haploid with a bipolar heterothallic mating system containing
one mating type locus, which occurs in either of the two alleles, a or α. Sexual reproduction
normally occurs between opposite mating types [20]. Serotype A is the predominant serotype,
being responsible for over 90% of all cases in HIV-positive patients [21–23]. The fact that the
mating type α is preponderant amongst environmental and clinical isolates of Cryptococcus
regardless of the serotype [24] raises the question of how sexual reproductionmight occur in
this unisexual population. Same-sex mating (α-α) occurs in nature as evidencedby the exis-
tence of αADα [25] and αAAα (VNII/VNB) hybrids [26, 27]. Furthermore, population genetic
studies detected sexual recombination in natural populations of both C. neoformans var. grubii
and C. gattii, where only the mating type α was identified, including α-only populations of C.
neoformans var. grubii veterinary isolates in Sydney, Australia [28], environmental C. neofor-
mans var. grubii isolates from tree hollows in north-western India [29] and C. gattii isolates
from Australian eucalyptus trees [30]. Phylogenetic analysis of the C. gattii outbreak strains
from Vancouver Island speculated that same-sexmating between two different mating type α
strains may have given rise to a more virulent strain which then occupied a new environmental
niche [31].
Multiple recent hybridization events ranging from present time to 2.158 million years ago
between strains of both serotypes A and D have been suggested to be responsible for the origin
and current distribution of AD hybrid strains [12]. As such, they contain alleles of both sero-
types and are diploid or aneuploid [10–12]. The clinical relevance of AD hybrids is emphasised
by their presence in several parts of the world. A European study of 311 clinical cryptococcal
isolates collected from 1997 to 2001, showed that 30% of the studied isolates were AD hybrids,
with the highest incidence being observed in Portugal (50%), Greece (48%) and Spain (45%)
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[23]. An analysis of clinical and environmental C. neoformans isolates in the United States
showed that 7.1% of the environmental and 2.4% of the clinical strains were AD hybrids [32].
Most serotype AD strains are heterozygous at the mating locus, presenting two opposite mat-
ing type alleles, αADa or aADα. Although, theMATa allele among isolates of serotype A is
rare, it is common in AD hybrids [9–11, 32]. Natural αADα hybrids that arose by fusion
between two α cells of different serotypes have been reported in SouthernAfrica and the USA
[25]. In addition, it has been reported that a small percentage of AD strains are homozygous at
the mating locus, presenting only one mating type allele [23, 33].
C. neoformans and C. gattii have a set of well-defined virulence factors which influence
pathogenicity of individual isolates, including melanisation, capsule production, phospholipase
B secretion and ability to grow at body temperature. These virulence properties enable C. neo-
formans and C. gattii to be the only two highly successful pathogens in the genus Cryptococcus
[20]. Several studies have shown that hybrids with different mating type allelic patterns differ
in virulence [10, 34, 35]. Diploid progeny of serotype A and D have been reported to be more
fit than their parental strains [36]. Isogenic hybrids showed that ploidy and mating type allelic
patterns do not affect the virulence in a mouse model and that higher ploidy has a minor effect
in reduction of virulence [37]. However, another study has shown that there is no correlation
betweenmating type locus pattern and mortality in a mouse model [38]. The true incidence of
clinical hybrid strains is unknown, as inter-varietal or inter-species hybrids are not routinely
identified in diagnostic laboratories, which may explain the small number of intra-varietal
hybrids reported to date [26, 27].
The current study set out to gain knowledge of the presence of hybrids in our large global
collection of C. neoformans/C. gattii strains using molecular and proteomics approaches, and
to obtain further insides into the genetic make up, antifungal susceptibility, virulence pheno-
types, and pathogenicity of potential hybrids, to provide insights into the impact of
hybridization.
Materials and Methods
Isolates and reference strains
A total of 365 global epidemiologically unlinkedC. neoformans clinical (n = 172), environmen-
tal (n = 15) and veterinary (n = 170) isolates were selected from the culture collection of the
MolecularMycology Research Laboratory at Westmead Hospital, Australia and screened for
the presence of potential hybrids. These isolates were from Australia (n = 202), South Africa
(n = 33), Brazil (n = 31), Colombia (n = 16), Peru (n = 10), Italy (n = 9), Thailand (n = 9), USA
(n = 9), New Zealand (n = 8), Argentina (n = 6), Belgium (n = 5), Chile (n = 3), India (n = 3),
Canada (n = 2), Greece (n = 2), Japan (n = 2), Spain (n = 2), Germany (n = 1), Kuwait (n = 1),
Mexico (n = 1), Venezuela (n = 1) and Zaire (n = 1). In addition, two hybrid strains from the
LaboratoryMicologiaMedica, Dipartmento di Scienze Biomediche per la Salute, Universita
degli studi di Milano, Milan, Italy were included in the study. Eight standard strains, represent-
ing each of the major molecular type of the C. neoformans/C. gattii species complex (WM 148
(VNI, Aα), WM 626 (VNII, Aα), WM 628 (VNIII, αADa), WM 629 (VNIV, Dα), WM 179
(VGI, Bα), WM 178 (VGII, Bα), WM 175 (VGIII, Bα), WM 779 (VGIV, Cα)) were used for
the identification of the major molecular types [4]. In addition, the following strains were
included as references for specific tests, e.g. mating type, serotype, virulence phenotype and
pathogenicity studies: H99 (VNI, Aα) [39], IUM 96–2828 (VNI, Aa) [40], JEC21 (VNIV, Dα)
[41], JEC20 (VNIV, Da) [41], CBS132 (VNIII, αADa) [11, 42], IUM 91–0804 (VNIII, aADα)
[11], CDCR265 (VGIIa, Bα) [43] and CDCR272 (VGIIb, Bα) [44]. Four additional inter-spe-
cies cryptococcalhybrids (WM 2617 (VNI/VGI, αABa), WM 05.272 (VNI/VGII, αABa), WM
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05.459 (VNI/VGII, αABa), WM 05.532 (VNI/VGII, αABa)) describedpreviously [19] were
used in the MALDI-TOFMS, antifungal susceptibility and virulence analyses.
Identification of hybrids
Genomic DNA of all isolates was extracted according to Ferrer et al. [45]. To determine the
molecular type of the isolates,URA5-RFLPwas first amplified with the primers URA5, 5'-
ATGTCCTCCCAAGCCCTCGACTCCG-3' and SJ101, 5'-TTAAGACCTCTGAACACCG
TACTC-3' and PCR products were digested withHhaI and Sau96I enzymes at 37°C over
night [4]. The molecular types were identified by comparison of each of the obtained profiles
with those of the eight standard strains of the eight major molecular types [4]. Isolates with
mixed patterns were considered potential hybrids. Luminex analysis was performed on poten-
tial intra-varietal hybrid isolates using the oligonucleotide probes described by Diaz and Fell
[46] and two probes specifically designed for the VNI and VNII molecular types [19] on the
Luminex 100 analyzer (Luminex Corporation,Austin, TX, USA) as describedpreviously by
Diaz and Fell [46] and Diaz et al. [47], and median fluorescent intensity (MFI) values were cal-
culated. The DNA content of hybrids was measured by flow cytometry as describedpreviously
[48]. Briefly, overnight grown cells were harvested from YPG (1% yeast extract, 1% pepton and
2% glucose)medium supplemented with 0.5 M sodium chloride and washed twice with dis-
tilled water. 107 cells/ml were fixed in 1 ml of 70% ethanol overnight at 4°C. Fixed cells were
washed with water and NS buffer (10 mMTris-Hcl (pH 7.2), 250 mM sucrose, 1 mM disodium
EDTA, 1 mMMgCl2, 0.1 mM ZnCl2) and then stained with 1 ml of propidium iodide
(10 μg/ml) in NS buffer containing RNase A (1 mg/ml) at 37°C for 3–4 h before incubation at
4°C overnight. Then cells were washed and diluted in 1 ml of 15 mM Tris-HCl (pH 8.0) and
sonicated for 1 min. Flow cytometrywas performed on 10,000 cells for each potential hybrid
isolate and analyzed with a BectonDickinson FACSCallibur instrument (BD Biosciences, San
Jose, CA, USA). Strain H99 (VNI, Aα) was used as haploid reference. Cells stained with propi-
dium iodide were examined by fluorescent microscopy to check the number of nuclei per cell.
Determination of mating type and serotype by PCR
The primer sets MFαF/MFαR and MFaF/MFaR [49], STE12αF809/STE12αR1607 and
STE12aF537/STE12aR1299 [17] were used to determine the mating type of the hybrid isolates.
To identify the serotype-specific allele combinations, the CAP59 gene was amplified and the
amplicons were digested using two separate restriction enzymes–BsmFI andHpaII as described
previously [50]. For the intra-varietal hybrid isolates the presence or absence of serotype A-
and D-specific alleles of theGPA1 gene was determined by PCR using the primer set
JOHE2596/JOHE3241 and JOHE2596/JOHE3240 [10] and for PAK1 gene the primer set
JOHE3066/JOHE3236 and JOHE3066/JOHE3065 D was used [25]. Moreover, several PCRs
were performed on intra-varietal hybrids for the serotype- and mating-type-specific genes
STE20α/a and SXI1α/2a, with the primer sets JOHE7264/JOHE7266, JOHE7267/JOHE7269,
JOHE7270/JOHE7271, JOHE7273/JOHE7274, JOHE15634/JOHE15635, JOHE15634/
JOHE15636, JOHE15629/JOHE15630 and JOHE15629/JOHE15631 as published previously
[25]. Primer sequences are listed in S1 Table.
Determination of α/α diploidization mechanism
To determine the mechanism of α/α diploid formation, polymorphisms in two highly diver-
gent loci located in the mating type locus (SXI1α, STE20α) and other polymorphic genomic
regions (GPD1, PLB1, SOD1,URA5 and IGS1) were examined after PCR amplification fol-
lowed by sequencing. Primer sequences and amplification conditions are listed in S2 Table. If a
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diploid α/α isolate resulted by mating between two genetically distinct α cells, the isolate would
show heterozygosis (nucleotide polymorphisms) at both theMAT locus and other genomic
regions [26].
Characterization of AD hybrids
To determinemating-type allelic pattern of AD hybrids a multiplex PCR was performedwith
four pairs of primers designed based on the nucleotide sequences of NCP1a,NAD4α, STE20a
and STE20αmating type-specific genes as describedpreviously [51]. To investigate the level of
heterozygosity of each AD hybrid, allele specific PCRs were performedwith serotype A- and
D-specific primers based on the sequences of 14 loci (IGS1,GPD1, SOD1, LAC1, PLB1, CAP59,
CAP10,URE1,GPA1, PAK1, CNA1, LBP,MDT and CDK) located on different chromosomes,
as describedpreviously [38]. The percentage of heterozygosity of each hybrid isolate was esti-
mated by dividing the number of heterozygous loci by the total number of loci analyzed.
Application of MALDI-TOF MS for identification of hybrid isolates
Test strains were grown on Sabouraud’s dextrose agar for 48 hr at 30°C. Protein extracts were
prepared using the ethanol-formic acid extraction protocol adopted from Bruker Daltonics
[52] as describedpreviously [53]. Briefly, 1 μl of the protein extract was placed on the target
position and overlaid with 1 μl of HCCA (α-cyano-4-hydroxy-cinnamic acid) matrix, (Bruker
Daltonics). Each sample was applied to 6 different spots on the plate. After air-drying the sam-
ples at room temperature, measurements were performedwith a Microflex LT mass spectrom-
eter (Bruker Daltonics). Spectral processing and identification were performed using
MALDI-Biotyper 3.0 software (Bruker Daltonics). For each tested isolate, using the MALDI
Biotyper Automation Control software version 2.0.43.8 (Bruker Daltonics), a composite of 6
spectra was generated, resulting in a main spectrum (MSP), which contains the frequencies of
the most significant peaks, average mass and intensity. The MSP of each isolate was used for
pattern matching against the extended Biotyper 3.0 library database and our in-houseMSP
library entries [40], consisting of 20 Cryptococcus isolates for each major molecular type (160
MSP) and identification scores were generated using the Biotyper 3.0 software (Bruker Daltro-
nics). Values of 2.300–3.000 are rated as a highly probable species identification, values of
2.000–2.299 are rated as secure genus identification with probable species identification.
G. mellonella survival assay and recovery of cryptococcal cells
Similar sized (approximately 250 mg body weight) G.mellonella larvae (20 larvae per strain)
were infected by injecting 106 fungal cells into the hemocoel at the last left pro-leg with a 26
gauge Hamilton syringe [54]. All larvae within an infected group were then transferred to a 90
mm plastic Petri dish loosely covered with aluminium foil and incubated at 37°C in the dark.
The larvae were observeddaily for 14 days and the number of dead larvae was scored daily.
Larvaewere considered to be dead when they failed to respond to gentle poking with forceps.
One group of control larvae was inoculatedwith PBS to ensure that death is not due to trauma
and that the buffer has no impact on larval viability and another group of larvae was not inocu-
lated to monitor the overall quality of the larvae during the course of the experiment. Killing
curveswere plotted by GraphPad Prism 6 (GraphPad Software, Inc., CA, USA) and the estima-
tion of differences in survival was analysed by the Kaplan-Meier method using SPSS Statistics
version 21.0 (IBM, NY, USA) statistical software. A p<0.05 was considered significant.
To recover cryptococcal cells from G.mellonella, larvae were mashed in 1 ml of PBS and fil-
tered through a strainer with a pore size of 100 μm (BD Biosciences, San Jose, California,
USA). Homogenates were washed twice with 1 ml of PBS and suspended in 150 μl of PBS.
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Cryptococciwere suspended in India ink, observedby microscopy and photographed. To mea-
sure differences in capsule and total cell size pre- and post-infection, cryptococcal cells grown
overnight in YPD broth were also observedby microscopy (20 cells for each isolate). Cell body
(delimited by cell wall) and capsule sizes were measured using QCapture Pro software v.
5.0.1.26 (QImaging, Surrey, BC, Canada). Total cell size was defined as the diameter of each
cell including the capsule. Capsule size was calculated as the difference in the diameter of the
cell plus capsule and the cell body. All cell and capsule measurements were log transformed to
approximate normality to establish the variance prior to analysis and paired t-tests were per-
formed using SPSS Statistics version 21.0 (IBM, NY, USA) software to compare the mean
change in ratio of capsule size to whole cell body size pre versus post inoculation. A Spearman
rank correlation was performed using the SPSS Statistics version 21.0 (IBM, NY, USA) between
median survival time and proportion of giant cells, median total cell size, median cell body size,
median capsule size and median ratio of capsule to total cell size after recovering the cells from
infected larvae for each tested isolate. Also, Spearman rank correlation was performed using
SPSS Statistics version 21.0 (IBM, NY, USA) betweenmedian survival time and median total
cell size, median cell body size, median capsule size and median ratio of capsule to total cell size
before and after injection to the larvae for each hybrid group and the control strains.
In vitro analysis of virulence factors
Hybrid and haploid control strains were grown overnight at 30°C in liquid YPD. Cells were
pelleted by centrifugation. Serial 10-fold dilutions of the cells were prepared in saline to deter-
mine cell density by counting using a haemocytometer. To analyze growth at high temperature,
cells were spotted on YPD agar and incubated at 37°C for 3 days. As a control, another set of
plates was incubated at 30°C. Production of melanin was tested at 30°C on melanin-inducing
L-DOPA agar medium [55, 56]. Melanization was identified by the development of dark
brown colonies after 3 days. To characterize capsule induction, 106 cells of each strain were cul-
tured on capsule-inducing RPMI-1640 agar and incubated for 2 days at 35°C in the presence of
5% CO2 [57, 58]. Cells were suspended in India ink and capsules were visualized by light
microscopy and measured using QCapture Pro v. 5.0.1.26 (QImaging, Surrey, BC, Canada). All
capsule measurements were log-transformed to approximate normality to establish the vari-
ance prior to analysis. Analysis of variance (ANOVA) was performed using the SPSS Statistics
software, version 21.0 (IBM, NY, USA). The mean ratio of capsule size to total cell size was
compared for each group of hybrids. Phospholipase activity was tested by inoculating 106 cells
on Sabouraud Dextrose Agar (SDA) containing 1 M sodium chloride, 0.005 M calcium chlo-
ride and 8% sterile egg yolk (Micromedia Laboratories, Vic, Australia). The plates were incu-
bated at 37°C for 7 days and the diameter of the zone of precipitation around the colonies was
measured. The ratio of the diameter of the colony to the diameter of the colony plus precipita-
tion zone (Pz) was measured as an index of phospholipase activity. A Pz value of 1.0 indicates
that the test strain is phospholipase negative [59].
In vitro antifungal susceptibility testing
Antifungal activity was determined by the Sensititre YeastOne YO9 Microdilution Test Panel
(Trek Diagnostics, UK) which is a microtitre broth dilution method based on the CLSI
M27-A3 standard [60]. Each test incorporates serial dilutions of amphotericin B, fluconazole,
itraconazole, posaconazole, 5-flucytosine and voriconazole. Plates were read after 72 hr of incu-
bation at 35°C. The MICs of each drug were log transformed prior to analysis.
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Results
Identification and molecular characterization of hybrids
From the 365 isolates studied, 19 isolates were identified as hybrids including 4 inter-species
isolates previously described [19], seven intra-varietal (VNI/VNII,αAAα) and eight inter-vari-
etal (VNII/VNIV, aADα) hybrid isolates. The specific characteristics of the identified hybrid
isolates is summarised in Table 1.
Intra-varietal (VNI/VNII, αAAα) hybrids
Comparison of theURA5-RFLPprofiles of all studied isolates with those of the standard refer-
ence strains revealed a unique hybrid pattern consistent with a composite of molecular types
VNI and VNII for seven serotype A isolates (Fig 1a). In 2001, one of the herein identifiedVNI/
VNII hybrids, WM 714, was reported as AFLP genotype 1 (corresponding to VNI), serotype A
isolate [61]. In 2008, the same isolate was characterized as AFLP genotype 1B (corresponding
to VNII), serotype A, mating type α diploid strain [27]. Determination of the ploidy using flow
cytometry analysis showed that all potential hybrid isolates contained ~2×more DNA (Fig 2b)
than the haploid control strain (Fig 2a), confirming that they were diploids. Fluorescent
microscopy showed that all cells were uninucleate. Using Luminex xMAP technology, the C.
neoformans specific probe (CNN b), C. neoformans var. grubii probe (CNN 1b), VNI specific
probe (CNN 1a/1b) and VNII specific probe (CNN 1c) gave positive signals for all VNI/VNII
hybrid isolates (data not shown). Therefore, these isolates were identified as hybrids of the
molecular types VNI and VNII. Restriction enzyme analysis of the CAP59 gene with BsmFI
andHpaII showed that all VNI/VNII hybrids had only the serotype A allele (S1 Fig). Mating
type and serotype- and mating-type-specificPCR analysis results for the VNI/VNII hybrids in
comparison with the reference strains are shown in S3 Table, indicating that all the VNI/VNII
hybrids were αAAα (Table 1). Analysis of the VNI/VNII hybrid isolates revealedmany hetero-
zygous sites when both mating type (SXI1α, STE20α) and other genomic loci (GPD1, PLB1,
SOD1,URA5 and IGS1) were sequenced, indicating that these α/α hybrids were most likely
derived from same-sex mating through fusion between two genetically distinct α cells of the
same serotype.
Inter-varietal (VNII/VNIV, aADα) hybrids
Comparison of theURA5-RFLPprofiles of all studied isolates with those of the standard refer-
ence strains revealed a novel mixed pattern between the molecular types VNII and VNIV for
six clinical isolates and two environmental isolates. The profiles of the VNII/VNIV hybrids
lack the VNI specific bands characteristic for the VNIII hybrids, which are a combination of
VNI, VNII and VNIV (Fig 1c). Using Flow cytometry, these hybrid strains were shown to con-
tain ~2×more DNA to that found in the reference haploid strain (Fig 2c). Fluorescent micros-
copy showed that all cells were uninucleate. Restriction enzyme analysis of the CAP59 gene
with BsmFI andHpaII showed the presence of both serotype A and D alleles for the VNIII
hybrids, except for the strain CBS132 (WM 01.123), which showed only the serotype D allele
(S2a Fig), as no digestion product cuts were obtained withHpaII. Moreover, theHpaII enzyme
could not digest the PCR product of VNII/VNIV hybrids (S2b Fig), which is most likely due to
the fact that the CAP59 primers used in this RFLP analysis are not able to amplify the Dα allele.
In the mating type analysis, all VNIII hybrids yielded amplicons with the primer sets specific
forMFα (MFαF/MFαR) andMFa (MFaF/MFaR). Positive amplifications were obtained for
the VNII/VNIV hybrids for both the STE12α and STE12a loci. Interestingly, simultaneous
mating-serotypemultiplex PCR showed the aADα sero/mating type combination for all VNII/
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VNIV hybrids and the αADa sero/mating type combination for all VNIII strains (Table 1),
except for strainWM 1355, which showed a Da pattern (Fig 3). The sero/mating type of the
Italian AD hybrids (UA2341 and UA2715) had been previously assigned as aADα by allele-
specific PCR of the mating type locus genes and sequencing of theMAT gene [38]. Analysis of
the allelic patterns of the selected genes for the AD hybrids showed that only one isolate, WM
01.80, with αADa sero/mating type pattern, was heterozygous at all loci. All other hybrids were
heterozygous in more than 79% of the studied loci, except for the strain CBS132, which showed
only 50% of heterozygosity (Table 2). For the isolates UA2341 and UA2715, the percentage of
heterozygosity was previously reported as 80% and 87%, respectively [38].
Application of MALDI-TOF MS for the identification of hybrid isolates
According to the MALDI-TOFMSmanufacturer’s criteria (spectral score2.0), all 20 studied
hybrid isolates were identified correctly to the species level (100% concordance with the
Fig 1. PCR-RFLP profiles of the a) VNI/VNII b) VNII/VNIV hybrid isolates as well as C. neoformans molecular types reference
strains obtained via double digest of the URA5 gene with HhaI and Sau96I. 1-kb+ DNA ladder (Invitrogen, Carlsbad, USA) was
used as molecular size marker. VNIII isolates were used for comparison to VNII/VNIV hybrids.
doi:10.1371/journal.pone.0163955.g001
Fig 2. Flow cytometry profiles of a) haploid control strain (H99, VNI), b) an example of αAAα (WM 2059,
VNI/VNII) and c) aADα hybrid (WM 1876 VNII/VNIV) isolates after staining with the fluorescent dye
propidium iodide. 1n, 2n, and 4n indicate nuclear content. The x-axis indicates fluorescence intensity
reflecting the DNA content, and the y-axis indicates cell counts.
doi:10.1371/journal.pone.0163955.g002
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reference spectra of five C. neoformans and two C. gattii strains currently included in the MAL-
DI-TOF Biotyper BDAL MSP library (Bruker Daltonics). Run against our in-house spectral
database for the C. neoformans/C. gattii species complex, containing spectra for 160 strains (20
per major molecular type), all hybrid isolates except two, were identified as hybrids belonging
to the expected group (identification scores of 2.101 to 2.634) (Table 1). One VNI/VNII isolate
(WM 2975) was recognized as a VNIII isolate. The VNI/VGI isolate (WM 2617) was recog-
nized as a VNI/VGII isolate, likely because there is only one VNI/VGI hybrid in the database
and the closest match was a VNI/VGII hybrid. The results of the present study have added 120
novel spectra for the different hybrid genotypes.
G. mellonella virulence studies
All hybrid isolates killed the G.mellonella larvae at 37°C, but the rate of killing varied between
the hybrid group strains. All VN/VG hybrids caused 100%mortality within 9 days of infection
(Fig 4a). All clinical VNI/VNII strains caused 100%mortality before day 14, except for strain
WM 2975 (which might be due to technical problems during inoculation) and the veterinary
isolate WM 714, which showed 20% and 85%mortality, respectively (Fig 4b). Clinical and
environmental VNII/VNIV (aADα) hybrids caused 0%-60%mortality, whereas the VNIII
(αADa) hybrids caused 100%mortality within 14 days (range 6–7 days) (Fig 4c). None of the
larvae inoculatedwith PBS died within the study period.
Fig 4d shows cumulative survival curves of larvae infected with different hybrid groups. S4
Table, summarizes the cumulative survival of larvae for each hybrid group and the control
strains. The VNI/VGII hybrid strains were significantlymore virulent than the VNI/VGI strain
(p<0.001). The highly virulent strain H99 (Aα) was significantlymore pathogenic than the
αADa (VNIII) (p<0.001), the VNI/VGI (αABa) (p = 0.002), the VNII/VNIV (aADα)
(p<0.001) and the VNI/VNII (αAAα) (p = 0.016) hybrids. There was no significant difference
Fig 3. Results of mating-serotype multiplex PCR for the hybrid isolates and reference strains. 1-kb = DNA ladder (Invitrogen,
Carlsbad, USA).
doi:10.1371/journal.pone.0163955.g003
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in survival rates in larvae infected with H99 and the VNI/VGII hybrids (αABa) (p = 0.547) and
the high virulent Vancouver Island outbreak strain, CDCR265 (VGIIa, Bα) (p = 0.070). All
hybrid strains were more virulent than the reference strain JEC20 (Da) (p<0.001) except for
the VNII/VNIV hybrids (p = 0.457) and strainWM 2975 (VNI/VNII) (p = 0.882). All the VN/
VG hybrids were also more virulent than the less virulent Vancouver Island outbreak strain,
CDCR272. A clear rank order of pathogenicity of hybrid groups and control strains was found
with H99 (Aα), CDCR265 (Bα), VNI/VGII (αABa)> VNI/VGI (αABa), VNIII (αADa)>
CDCR272 (Bα)> VNII/VNIV(aADα), JEC20 (Da). Larvae infected with the VNI/VNII
hybrids exhibited 50% mortality by day 4 post-infection.However, as the larvae infected with
the strains WM 2975 andWM 714 exhibited a lower killing rate, based on statistical analysis
this group of hybrids showed only a significant difference from the VNI/VGII hybrids
(p = 0.005), H99 (p = 0.016), VNII/VNIV hybrids (p<0.001) and JEC20 (p<0.001) and there-
fore could not be included in the pathogenicity rank order.
Cell and capsule size
The total size of hybrid cells (including capsule) following overnight growth in YPD broth ran-
ged between 5.08–15.58 μm (mean value 7.91 μm) (Fig 5a) whereas those recovered from larvae
ranged between 8.81–43.86 μm (mean 18.54 μm) (Fig 5b), which was more than 2-fold greater
than the average size observed in vitro (7.9 μm). This was due to both an increase in the cell
body and capsule size (Fig 6). The total size of haploid cells (including capsule) following
Table 2. Characteristics of AD hybrid isolates and reference strains investigated in this study and allelic patterns and percentage of heterozygo-
sis of the genes investigated.
Strain molecular
type
Mating/
serotype
IGS1 SOD1 LAC1 PLB1 CAP59 GPD1 CAP10 URE1 GPA1 CNA1 PAK1 LBP MDT CDK %
HZ
WM
1876
VNII/VNIV aADα AD AD AD A AD A AD AD AD D AD AD AD AD 79
WM
1693
VNII/VNIV aADα AD AD AD AD A D AD AD AD AD AD AD D AD 79
WM
09.183
VNII/VNIV aADα AD AD AD AD AD A AD AD AD AD AD AD AD AD 93
WM
1877
VNII/VNIV aADα AD AD AD AD AD A AD AD AD AD AD AD AD AD 93
WM
09.184
VNII/VNIV aADα AD AD AD AD AD A AD AD AD AD AD AD AD AD 93
WM
05.549
VNII/VNIV aADα AD AD AD AD AD A AD AD AD AD AD D D AD 79
UA2341 VNII/VNIV aADα AD AD AD AD A A AD AD AD AD AD AD D AD 79
UA2715 VNII/VNIV aADα AD AD AD AD AD A AD AD AD D AD AD AD AD 86
WM 628 VNIII αADa AD AD AD AD AD AD AD AD A AD AD AD AD AD 93
WM
1529
VNIII αADa AD AD AD AD AD AD AD AD AD D AD A AD AD 86
WM
01.80
VNIII αADa AD AD AD AD AD AD AD AD AD AD AD AD AD AD 100
WM
1355
VNIII αADa AD AD AD AD AD AD AD AD A D AD A AD AD 79
CBS132 VNIII αADa AD AD D A D AD AD D A D AD AD AD D 50
H99 VNI αA A A A A A A A A A A A A A A 0
JEC21 VNIV αD D D D D D D D D D D D D D D 0
HZ: Heterozygosis.
doi:10.1371/journal.pone.0163955.t002
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 12 / 28
Fig 4. Survival curves of larvae infected with the different hybrid strains. a) VN/VG hybrids, b) VNI/VNII hybrids, c) VNII/VNIV
versus VNIII hybrids, and d) cumulative survival curves comparing the different hybrid groups.
doi:10.1371/journal.pone.0163955.g004
Fig 5. Estimation of total cell and capsule size by India ink staining. a) Cells grown overnight in YPD broth. b) Cells recovered
from larvae infected with a hybrid isolate (106 cells/larva) c) giant cells recovered from larvae infected with hybrid isolate, WM 1986
(106 cells/larva).
doi:10.1371/journal.pone.0163955.g005
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overnight growth in YPD broth ranged between 5.44–10.89 μm (mean value 7.91 μm) whereas
those recovered from larvae ranged between 6.81–29.48 μm (mean 16.38 μm). Therefore, the
mean value of the total cell size of the hybrids was bigger than the haploid control strains before
and after injection to larvae. Among all hybrid groups and control strains, the VNI/VGI hybrid
Fig 6. Distribution of total cell size, cell body size and capsule diameter of individual isolates in each
hybrid group and the haploid control strains after overnight growth in YPD broth (*) and recovered
from the G. mellonella larvae after inoculation of 106 yeast cells (˚). Bars denote the average of distribution
and standard deviation.
doi:10.1371/journal.pone.0163955.g006
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showed the biggest average total cell and capsule size during infection in the G.mellonella lar-
vae and strain H99 showed the smallest of all cell sizes (S3 Fig). Comparing the VNIII and the
VNII/VNIV hybrids, the VNII/VNIV hybrids showed a notably bigger average capsule and
total cell size during infection in the G.mellonella larvae and the VNIII strains showed the
smallest capsule and total cell size compared to the other hybrid groups (S3 Fig).
There was a significant difference in the ratio of capsule size to the total cell size of cells
recovered from YPD broth between different groups of hybrids and control strains (p<0.001).
Therefore, the mean change in the ratio of the capsule size to the total cell body size of the cells
before and after injection in the larvae for all hybrid groups and control strains was calculated
with 95% confidence intervals (Table 3). The results showed a significant difference for all
hybrid groups (p0.001). As per colour code in Table 3, VNI/VGI, VNI/VGII and VNII/
VNIV hybrids were comparable and showed the biggest change compared with the other
hybrids and control strains. The VNI/VNII hybrids and the strain CDCR272 were comparable
and the VNIII hybrids did not group with any other hybrid group or the control strain. The
strains CDCR265, JEC20 and H99 were comparable with the smallest change in ratio.
In addition to capsule enlargement, giant cells (above 30 μm) were observed in all three
hybrid groups, which was due to both capsule enlargement and increase of the cell body size
(Fig 5c). The proportion of giant cells recovered from the larvae infectedwith strains WM
05.532 (VNI/VGII) and WM 1877 (VNII/VNIV)was 10%, for strainWM 2617 (VNI/VGI)
andWM 05.549 (VNII/VNIV) it was 5%, and for strainWM 1986 (VNI/VNII) it was 4.8%.
There was no correlation betweenmedian survival time with mean change in ratio of capsule
size to the total cell body size of cells of each hybrid group or the control strains before and
after injection to the larvae (correlation coefficient: -0.009; p = 0.983), median ratio of capsule
size to the total cell body size of cells before (correlation coefficient: 0.051; p = 0.896) and after
(correlation coefficient: 0.051; p = 0.896) injection to the larvae, median total cell size before
(correlation coefficient: 0.306; p = 0.424) and after (correlation coefficient: 0.185; p = 0.634)
injection to the larvae, median capsule size before (correlation coefficient: 0.185; p = 0.633) and
after (correlation coefficient: 0.077; p = 0.844) injection to the larvae. Also, no correlation was
found betweenmedian survival time with median total cell size (correlation coefficient: -0.141;
p = 0.52), median cell body size (correlation coefficient: -0.02; p = 0.929), median capsule size
(correlation coefficient: -0.163; p = 0.459) and median ratio of capsule size to the total cell size
Table 3. Changes in the mean ratio of capsule size to the total cell body size of cells before and after injection to the larvae with 95% confidence
intervals and geometric mean of capsule size and mean ratio of capsule:total cell size for different hybrid groups and haploid reference strains.
Hybrid
group/
control
strain
Change in mean
ratio pre-post
injection
95% Confidence
Interval for change
in mean ratio
p-value for
change in
mean ratio
Geometric mean
of capsule size
95% confidence
interval for
geometric mean
Mean ratio
capsule:total
cell size
95% confidence
interval for mean
Lower
bound
Upper
bound
Lower
bound
Upper
bound
Lower
bound
Upper
bound
VNI/VGI 0.34 0.30 0.38 <0.001 5.42 5.00 5.87 0.52 0.50 0.54
VNI/VGII 0.31 0.29 0.34 <0.001 8.21 7.68 8.77 0.61 0.59 0.63
VNII/VNIV 0.30 0.28 0.32 <0.001 6.24 6.02 6.46 0.50 0.49 0.51
CDC R272 0.19 0.14 0.25 <0.001 5.67 5.00 6.42 0.47 0.44 0.50
VNI/VNII 0.17 0.14 0.19 <0.001 6.33 6.00 6.68 0.51 0.49 0.52
VNIII 0.11 0.06 0.16 <0.001 2.82 2.64 3.01 0.31 0.29 0.32
CDC R265 0.08 0.03 0.13 0.001 4.22 3.98 4.46 0.39 0.37 0.40
JEC20 0.04 -0.01 0.08 0.084 6.03 5.63 6.45 0.48 0.46 0.50
H99 0.02 -0.02 0.07 0.276 2.35 2.18 2.55 0.26 0.24 0.27
doi:10.1371/journal.pone.0163955.t003
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 15 / 28
(correlation coefficient: -0.083; p = 0.706) after recovering the cells from infected larvae for
each individual hybrid or the control isolates. Moreover, there was no correlation between the
median survival time and proportion of giant cells (correlation coefficient: 0.022; p = 0.922).
Virulence factors
All hybrids and the haploid reference strains grew well at 37°C, similar to their growth at 30°C,
although their rate of growth varied slightly (Fig 7). The production of melanin during growth
on L-DOPA medium at 37°C was observed in all hybrids and the haploid reference strains
(H99, CDCR265, CDCR272) but not in the low virulent JEC20 (Da) strain (negative control)
Fig 7. In vitro assays of melanin production on L-DOPA agar, growth at 37˚C on YPD agar and growth on
YPD agar at 30˚C as growth control for hybrid and haploid strains.
doi:10.1371/journal.pone.0163955.g007
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(Fig 7). Based on light microscopy all tested strains produced a capsule after incubation at 35°C
in RPMI-1640 agar medium, as demonstrated by negative staining with India ink (Fig 5). All
isolates secreted phospholipase as indicated by white zones of precipitation around the colo-
nies. Zone sizes varied depending on the isolate. Phospholipase production, expressed as the Pz
value, of tested isolates is summarized in Table 1. Means of phospholipase zone (Pz) index
were 0.8 (±0) for VNI/VGI, 0.76 (±0.04) for VNI/VGII, 0.65 (±0.08) for VNI/VNII, 0.61
(±0.06) for VNII/VNIV and 0.71 (±0.02) for VNIII.
Antifungal susceptibility
All hybrid isolates were susceptible to all tested drugs except for 5-flucytosine,which was inter-
mediate (MIC = 8) for WM 05.272 (VNI/VGII, αABa) when compared with the breakpoints
for antifungal susceptibility established for Candida spp.
No significant differences were found in the MICs betweenVNI/VNII, VNII/VNIV and
VN/VG hybrid groups (p = 0.579). MICs were significantly different for each tested drug
(p<0.001), except for posaconazole and itraconzole, which showed similar activity (p = 0.973).
Fig 8 shows azoles, 5-flucytosine and amphotericin B MIC (μg/ml) distributions for Cryptococ-
cus hybrid strains. Azoles were compared with epidemiological cut off values (ECVs) for Cryp-
tococcus neoformans/Cryptococcus gattii species complex describedpreviously [65]. The MICs
of all hybrids against the azoles were below or equal to the parental molecular types and species
ECVs (Fig 8). Since no ECVs are reported for 5-flucytosine and amphotericin B, geometric
mean of all hybrid genotype groups were compared with the calculated GM of published rele-
vant molecular types, serotypes and species (Table 4). Previously published data are listed in S5
Table. The geometricmean of the VNI/VNII and VNII/VNIV hybrids was lower than the pub-
lished GMs against the parental molecular types, serotypes and species for amphotericin B and
5-flucytosine.Amphotericin B MIC for the VNI/VGI hybrid was lower than publishedMICs
of all relevant molecular types, serotypes and species. However, 5-flucytosineMIC for the VNI/
VGI hybrid was higher than publishedMICs of all parental molecular types, serotypes and spe-
cies. The GM of the VNI/VGII hybrids was equal or lower than the published GMs for VNI,
VGII, serotypes A and B, C. neoformans and C. gattii for amphotericin B except for the sero-
type B for which the MICs GMwas slightly higher. The GM of the VNI/VGII hybrids was
lower than the published GMs for VNI, VGII, C. neoformans and C. gattii but higher than sero-
types A and B for 5-flucytosine (Table 4).
Discussion
Although most naturally-occurringCryptococcus hybrid strains are clinical and environmen-
tal inter-varietal AD hybrids [8, 11, 12, 23, 32, 34, 61, 66], several clinical inter-species
hybrids between serotypes A and B [18, 19] and B and D [17] have been described.Addition-
ally, naturally-occurring clinical and environmental intra-varietal αAAα hybrids have been
reported [26].
In this study, seven natural αAAα hybrid strains from clinical and veterinary sources were
identified and characterized. These strains were homozygous for the serotype A-specific allele
and theMATα mating type locus. This result is consistent with the α-mating type predomi-
nance in the serotype A population [26]. The herein reported hybrids betweenVNI and VNII
are either additional proof for previously reported intra-varietal hybrids betweenVNII and
VNB [26, 27] or in fact represent a new hyrbid type, for which final confirmation is subject to
further studies, which may need to include the originally describedVNII/VNB hybrid strains
[26]. Our findings, taken together with previous reports of α/α diploids resulting from same-
sex mating, emphasizes the importance of this process for generating genetic diversity and to
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Fig 8. MICs (μg/ml) of azoles, 5-flucytosine and amphotericin B against Cryptococcus hybrid strains compared with
epidemiological cut off values (ECVs) for Cryptococcus neoformans/Cryptococcus gattii species complex.
doi:10.1371/journal.pone.0163955.g008
Table 4. MICs (μg/ml) geometric mean (GM) values of 5-flucytosine and Amphotericin B against different cryptococcal hybrid groups and calcu-
lated combined overall previously published MICs ranges and GM of each haploid group within the C. neoformans/C. gattii species complex.
Hybrid group VNI/VNII
(αAAα)
VNII/VNIV
(aADα)
VN/VG
(αABa)
VNI Serotype
A
Serotype
D
Serotype
AD
C.
neoformans
VGI VGII Serotype
B
C.
gattii
GM GM GM GM GM GM GM GM GM GM GM GM
5-flucytosine 2 2.519 3.363 3.43 3.123 3.204 4.443 3.6 1.667 4 1.66 3.304
Amphotericin
B
0.205 0.14 0.21 0.56 0.25 0.156 0.174 0.335 0.356 0.44 0.239 0.363
doi:10.1371/journal.pone.0163955.t004
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assist this fungus to compensate for a mainly unisexual population structure. Our data are also
consistent with the notion that intra-varietal hybridization is likely to occur at a low frequency
in nature [26]. These hybrids may not be easily recognized due to sensitivity limitations associ-
ated with most of the commonly used typing techniques. The detection of αAAα hybrids in
both Colombia and Australia as described in this study, suggests that the intra-varietal same-
sex mating process is not restricted to specific geographic regions or less likely that the hybrid
strains clonally expanded and becamewidely dispersed.
The new pattern VNII/VNIV is associated to mating type aADα hybrids, whereas the pat-
tern VNIII is associated to αADa allelic pattern. These findings suggest that, in the aADα
hybrids here investigated, theURA5 allele A is from the VNII strains and therefore that Aa
MAT locus originated from the VNII population. This is also supported by the existence of nat-
ural isolates belonging to molecular type VNII and mating type α as shown in the case of strain
IUM 96–2828 [40]. The results obtained by M13 PCR-fingerprinting showed different profiles
for αADa and aADα isolates indicating genetic variation between them. This was consistent
with the previously reported AFLP genotypes of αADa and aADα strains [66].
The allelic pattern obtained for strain CBS132 was identical to the one reported previously
[38], confirming the reproducibility of the method and the stability of the hybrid genome. The
fact that the majority of AD strains are heterozygous for many but not all genetic markers ana-
lysed might be due to gene conversion, deletion and/or chromosome loss. Loss of heterozygos-
ity is likely to be common following hybridization between strains of serotype A and D. Allelic
losses for many of the loci examined in the AD strains have been previously reported [10, 38,
67]. Genetic and phenotypic changes have been reported for C. neoformans strains during pro-
longed asexual propagation and suboptimal storage in the laboratory [7, 68]. It has been sug-
gested that hybridization followed by differential loss of heterozygosity could be an important
mechanism for generating genetic variation in C. neoformans [12].
The current study investigated the genome heterozygosis of several AD hybrids, found no
correlation betweenmolecular type or mating type allelic pattern and level of heterozygosity in
the hybrid isolates. A high level of heterozygosity was obtained for the majority of AD hybrids
studied, suggesting that heterozygosis could enhance the fitness of C. neoformans. A variable
percentage of heterozygosis was observed in the AD hybrids even within each sero/mating type
group. The fact that some loci were homozygous and that heterozygous regions were distrib-
uted randomly supports the hypothesis that C. neoformans hybrids originated from a post-mei-
otic event [33].
MALDI-TOFMS as shown previously can not only distinguish betweenC. neoformans and
C. gattii [69], but also betweenC. neoformans var. neoformans from C. neoformans var. grubii
and AD hybrids [70]. Furthermore, it can recognise different cryptococcalgenotypes [70]. The
current study showed that MALDI-TOF can also identify cryptococcalhybrids. Moreover, it
strongly suggests that MALDI-TOF can distinguish inter-species, intra-varietal and inter-vari-
etal hybrids and identify their composite molecular types in agreement with the DNA-based
typing methods. Finally it confirms the highly discriminatory potential of MALDI-TOFMS as
a powerful technique for the routine identification of hybrids from other strains and from each
other within the C. neoformans/C. gattii species complex. The discordant result in identifica-
tion of one VNI/VNII isolate, which was recognized by MALDI-TOFMS as a VNIII isolate,
and one VNI/VGI isolate, which was recognized as a VNI/VGII isolate, is most likely due to
the lack of reference spectra for hybrid strains in the database. Future improvement of the data-
base by addition of more spectra obtained form hybrids should reduce these misidentifications.
To our knowledge this is the first study in which the pathogenicity of different groups of
hybrids was compared in a G.mellonellamodel.G.mellonella is a recent model applied to
study Cryptococcus spp. pathogenicity [71]. It takes advantage of the phagocytic haemocytes
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which phagocyte and kill bacterial and fungal cells by a mechanism similar to that used by
human neutrophils, namely, via the production of superoxide [72]. G.mellonella larvae have
been used to study the pathogenesis of other fungal infections which also affect humans, such
as those caused by Candida albicans, Aspergillus fumigatus and A. flavus [73–76]. The results
showed that hybrid strains containing the Aαmating type locus are highly virulent in the G.
mellonellamodel. These results are consistent with a previous study by Kwon-Chung et al.,
which reported that there is a relationship betweenmating type and virulence,withMATα
beingmore virulent thanMATa strains [41]. The VNI/VGII (αABa) hybrids were found to be
as virulent as the haploid virulent strains H99 and CDCR265. The VNI/VGI (αABa) and the
VNIII (αADa) hybrids were virulent but less so than strain H99. Similarly, it has been reported
that hybrid strains containing the Aαmating type locus were highly virulent in the murine tail
vein injectionmodel and haploid Aα strains were more virulent than haploid Aa and Da
strains [35]. Haploid and diploid strains containing the Dα allele have exhibited a wide range
of virulence [35]. The virulence of AD hybrids has been reported intermediate between the ref-
erence strains H99 (Aα) and JEC20 (Da), with the aADα hybrids showing much lower viru-
lence [35]. Two other studies have shown that haploid Aa strains are considerably less virulent
than strain H99 [77, 78]. Virulence of eight αADa hybrid strains in an experimental intrave-
nous mouse model was similar to strain H99 [34]. Lengeler et al. tested two αADa and two
aADα hybrid strains and found that one αADa strain was virulent but less than strain H99.
The rest of the tested strains were moderately virulent [10]. Another study on laboratory-gen-
erated αADa and aADα hybrid strains suggested that their virulence is close to the haploid
serotype A parental strains [37]. However, our results showed that αADa hybrids are virulent,
but less so than strain H99. The aADα hybrid strains were not as virulent and grouped together
with the low avirulent serotype D strain JEC20. The difference in virulence betweenαADa and
aADα strains is likely due to the difference in genotype. This suggests that the serotype origin
of the mating type plays a role in virulence and the presence of Aα confers an advantage in vir-
ulence as it has been suggested in previous studies [34, 35] with the α allele from serotype A
being associated with higher virulence in AD hybrids [35]. This hypothesis is supported by the
previous observation of reduced pathogenicity of aADa hybrids compared with other AD
hybrids [37]. The difference between virulence of natural and laboratory generated hybrids
might be due to the independent origin of the natural isolates, with different genetic back-
grounds and a considerable mitotic expansion in nature [12].
The results of this study showed that natural αAAα hybrids are as virulent as or less than
Aα (H99) haploid strains, which confirmed previous findings showing that isogenic αAAα
hybrid strains are slightly less virulent than haploid serotype A strains, but still highly virulent,
suggesting that higher ploidy may modestly reduce virulence in the host [37].
It has been shown that C. neoformans undergoes a large increase in both capsule size and
cell body size duringmammalian pulmonary infection [79, 80] and in theG.mellonella infec-
tion [81]. Similar changes occurred in the hybrid strains, as they manifested a significant
increase in the average capsule and total cell size duringG.mellonella larvae infection. In addi-
tion to capsule enlargement, the appearance of giant cells has been reported in cryptococcal
infections in the murine [80, 82] and G.mellonella [81] models, as was also shown in the cur-
rent study for cryptococcalhybrid strains. Emergence of giant cells in both the mouse and the
G.mellonellamodels indicates that this phenomenon is not host specific. Although giant cells,
which have been recovered from G.mellonella had similar properties to the giant cells obtained
frommice, the ones isolated frommice were larger [80]. A possible explanation for this is the
length of infection, which is longer in mice and gives more time to yeast cells to become larger
than in the insect model due to short lifespan of the infected larvae [81], reemphasising that
the formation of giant cell is an age-dependent phenomenon [80]. This may also explain the
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observations of the current study, which showed a bigger capsule and total cell size for the
VNII/VNIV hybrids compared with the VNIII hybrids, or the serotype D strain JEC20 com-
pared with the high virulent serotype A strain H99, or the VNI/VGI hybrids compared with
the VNI/VGII hybrid, with the later having a lower median survival time, as the cells were
recovered from the larvae after they died.
Except for the low virulent Vancouver Island outbreak haploid strain CDCR272, other
studied haploid strains had the least mean change in ratio of capsule to the total cell size pre
versus post injection of the larvae compared with the hybrid isolate. This indicates that the cap-
sule of the hybrid strains became bigger than the haploid strains during infection (Table 3).
The mean ratio of capsule:total cell size was almost similar under in vitro and in vivo capsule
induction conditions. The exception was the strain CDCR272, which showed a biggermean
ratio of capsule:total cell size in vivo compared to in vitro capsule induction conditions.
In terms of capsule production, the haploid reference strains had smaller ratios of capsule:
total cell size than the hybrids. The results of this study show no correlation between capsule/
total cell size and virulence. This was consistent with a previous study on virulence of giant
cells, for which the same virulence capacity as regular size cells had been observed [81]. Look-
ing at the capsule size, no correlation between the in vitro capsule size and virulence or the cap-
sule size indexes and allelic patterns of the CAP59 and CAP10 genes was found, confirming
similar findings on AD hybrids reported previously [38].
In vitro virulence factor assays indicated that AD hybrids, except for strain CBS132, pro-
duced less melanin than the other hybrid groups. Within the VN/VG hybrids, the VNI/VGI
showed weaker melanisation than the VNI/VGII hybrids. This may reflect their genotype dif-
ferences and independent origins. All AD hybrids exhibited similar phenotypes regardless of
the sero/mating type combination and their melanisation was intermediate compared to that
of their respective haploid parents. No difference in melanin production was observed in other
hybrid groups compared with their respective haploid parents. Studies on 19 AD hybrid iso-
lates, found that the LAC1 heterozygous pattern is not associated with differences in melanin
production [38]. However, the current study showed that all AD hybrids are heterozygous at
the LAC1 locus, except for CBS132 (VNIII), which was homozygous for allele D. Interestingly,
the intensity of melanin production in this strain was greater than that of the other AD hybrids,
suggesting that heterozygosis at the LAC1 locusmay not only not enhance the production of
melanin, it could even have an adverse effect on melanin production.
It has been reported that isolates of both C. neoformans and C. gattii produce similar
amounts of phospholipase [83]. In addition, no statistically significant difference in phospholi-
pase production was found in a study of phospholipase activity of 19 AD hybrid isolates [38].
This is consistent with our findings showing no significant difference between phospholipase
activity between different hybrid groups and between hybrids and haploid controls regardless
of the mating type and serotype combination. Moreover, clinical, veterinary and environmental
hybrid isolates exhibited similar phospholipase production, confirming previous findings in
clinical and environmental isolates of C. neoformans [83].
All hybrid strains behaved similarly in terms of their growth at human physiological tem-
perature. The results of the current study showed no correlation between heterozygosity and
growth at high temperature, but growth of the AD hybrids was slower than that of their haploid
parents, regardless of being heterozygous or homozygous. Also, there was no correlation
between virulence in theG.mellonellamodel and heterozygosity of the αADa and aADα
hybrids. However, a previous study showed that heterozygous AD strains grew better than
parental haploids at high temperatures and after UV irradiation, whereas homozygous hybrids
grewmore slowly than heterogygous hybrids and haploids at both high and low temperatures
and after UV irradiation [38].
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 21 / 28
All tested antifungal compounds were active against all the tested hybrid strains, with flu-
conazole and 5-flucytosine having the highest MICs followed by amphotericin B. Posaconazole
and itraconazole showed relatively lowMICs compared with those of the other antifungal com-
pounds. Voriconazole demonstrated excellent potency against each hybrid isolate. These
results are comparable to the ones found for haploid C. gattii and C. neoformans strains [84–
87]. Except for 5-flucytosine, posaconazole and itraconazole the VNI/VGII hybrids were less
susceptible than the VNI/VGI hybrid isolate for all other tested drugs, reflecting previous find-
ing, that the molecular type VGII is less susceptible than VGI [84, 88, 89]. Within the VNI/
VNII group, WM 05.269 andWM 714 were more susceptible to 5-flucytosine, voriconazole,
itraconazole and fluconazole compared with the other isolates in this group. Interestingly, in
the virulence study these isolates produced less melanin and showed less virulence than the
other isolates in the group. Overall, it can be concluded that hybridization may have a positive
effect on antifungal susceptibility, as the studied hybrids showed equal or more susceptibility to
antifungal agents compared to their parents.
In summary, hybrid strains comprise an important component of the C. neoformans/C. gat-
tii species complex. They are recovered from clinical isolates and show relative similar virulent
phenotypes in the experimentalG.mellonellamodel, except for the VNII/VNIV (aADα)
hybrids. Hybrids can undergo capsule enlargement and produce giant cells as their haploid
parents, which might be a general adaptation tool for persistence and fungal survival in the
host. This study has provided additional new insights in the overall population structure and
the role of hybrids for the evolution of this important human/animal pathogen.
Supporting Information
S1 Fig. Restriction profiles of CAP59 gene for VNI/VNII hybrid isolates and reference
strains of different serotypes of C. neoformans on 3% agarose gel with BsmFI andHpaII
restriction enzymes.LaneM, 1-kb+ DNA ladder (Invitrogen, Carlsbad, USA).
(PDF)
S2 Fig. Restriction profiles of CAP59 gene obtained with the BsmFI andHpaII restriction
enzymes for VNIII hybrid isolates (a) and VNII/VNIV hybrid isolates (b) and reference
strains separatedon 3% agarose gel. 1kb+ = DNA ladder (Invitrogen, Carlsbad, USA).
(PDF)
S3 Fig. Distribution of total cell size, cell body size and capsule diameter of all isolates in
each hybrid groups and haploid control strains in Sabouraud () and recovered from theG.
mellonella larvae after inoculation of 106 yeast cells (°). Bars denote the average of distribu-
tion and standard deviation.
(PDF)
S1 Table. PCR primer sequencesused in this study.
(PDF)
S2 Table. Loci information outside themating locus used for determination of α/α diploi-
dization mechanism.
(PDF)
S3 Table. Mating type and serotype- andmating-type-specificPCR analysis results for the
VNI/VNII hybrid isolates in comparisonwith reference strains.
(PDF)
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 22 / 28
S4 Table. Cumulative survivalof larvae for each hybrid group and control strains.
(PDF)
S5 Table. Summary of previously published data of MICs (μg/ml) range and geometric
mean (GM) values of 5-flucytosineand Amphotericin B agents against different cryptococ-
cal strain groups.
(PDF)
Acknowledgments
We would like to thank the members of the ISHAM working group for genotyping of C. neo-
formans and C. gattii for supplying the strains screened in this study, specifically Joseph Tor-
rers-Rodriquez,Univesitat Autonoma de Barcelona, Barcelona, Spain; MarryMatthews,
Department of ClinicalMicrobiology, ChristianMedical College, Vellore, India; Yuzuru
Mikami, Medical Mycology Research Center (MMRC), Chiba University, Chiba, Japan; and
Richard Malik, Centre for Veterinary Education, The University of Sydney, Sydney, Australia.
We would like to thankMara Diaz, Rosenstiel School of Marine and Atmospheric Sciences,
University of Miami, Miami, FL, USA, for supplying the Luminex probes. We would like to
thank Diana Leemon, Agri ScienceQueensland, Department of Agriculture Fisheries and For-
estry, Brisbane, QLD, Australia, for supplying the Galleria mellonella larvae.We would like to
thank Karen Byth, Research and Education Network, Westmead Hospital, Sydney for their
help with the statistical analysis.
Author Contributions
Conceptualization:M. Aminnejad ECML TSWM.
Data curation:M. AminnejadWM.
Formal analysis:M. AminnejadMC.
Funding acquisition:WMTS.
Investigation:M. Aminnejad SDMC.
Methodology:M. Aminnejad SDMC.
Project administration:WM.
Resources:M. Arabatzis AV DE KT ECMC TSWM.
Supervision:WMTS.
Validation: M. Aminnejad SDMC.
Visualization:M. Aminnejad.
Writing – original draft:M. AminnejadWM.
Writing – review& editing:M. AminnejadM. Arabatzis AV DE KT ECMCWM.
References
1. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006; 20(3):507–44. doi: 10.
1016/j.idc.2006.07.001 PMID: 16984867
2. Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: develop-
ments and challenges. Expert Opin Pharmacother. 2008; 9(4):551–60. doi: 10.1517/14656566.9.4.
551 PMID: 18312157
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 23 / 28
3. Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, et al. Consensus multi-locus
sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009; 47
(6):561–70. doi: 10.1080/13693780902953886 PMID: 19462334
4. Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E. Molecular typing of IberoAmerican Cryp-
tococcus neoformans isolates. Emerg Infect Dis. 2003; 9(2):189–95. doi: 10.3201/eid0902.020246
PMID: 12603989
5. Kwon-Chung K, Bennett J. Epidemiologic differences between the two varieties of Cryptococcus neo-
formans. Am J Epidemiol. 1984; 120(1):123–30. PMID: 6377880
6. Brandt ME, Hutwagner LC, Klug LA, Baughman WS, Rimland D, Graviss EA, et al. Molecular subtype
distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease
Active Surveillance Group. J Clin Microbiol. 1996; 34(4):912. PMID: 8815107
7. Viviani M, Wen H, Roverselli A, Caldarelli-Stefano R, Cogliati M, Ferrante P, et al. Identification by
polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD. Med Mycol. 1997;
35(5):355–60.
8. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RCL, et al. Serotyping of
467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of
host and regional patterns. J Clin Microbiol. 2003; 41(1):73–7. doi: 10.1128/JCM.41.1.73-77.2003
PMID: 12517828
9. Yan Z, Li X, Xu J. Geographic distribution of mating type alleles of Cryptococcus neoformans in four
areas of the United States. J Clin Microbiol. 2002; 40(3):965–72. doi: 10.1128/JCM.40.3.965-972.2002
PMID: 11880424
10. Lengeler KB, Cox GM, Heitman J. Serotype AD strains of Cryptococcus neoformans are diploid or
aneuploid and are heterozygous at the mating-type locus. Infect Immun. 2001; 69(1):115–22. Epub
2000/12/19. doi: 10.1128/IAI.69.1.115-122.2001 PMID: 11119496; PubMed Central PMCID:
PMC97862.
11. Cogliati M, Esposto MC, Clarke DL, Wickes BL, Viviani MA. Origin of Cryptococcus neoformans var.
neoformans diploid strains. J Clin Microbiol. 2001; 39(11):3889–94. Epub 2001/10/30. doi: 10.1128/
JCM.39.11.3889-3894.2001 PMID: 11682503; PubMed Central PMCID: PMC88460.
12. Xu J, Luo G, Vilgalys RJ, Brandt ME, Mitchell TG. Multiple origins of hybrid strains of Cryptococcus
neoformans with serotype AD. Microbiology. 2002; 148(1):203–12.
13. Litvintseva AP, Rameshwari T, Rytas V, Mitchell TG. Multilocus sequence typing reveals three genetic
subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in
Botswana. Genetics. 2006; 172(4):2223–38. doi: 10.1534/genetics.105.046672 PMID: 16322524
14. Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, Tsui KM, et al. Genetic diversity
of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties.
PLoS One. 2009; 4(6):e5862. Epub 2009/06/12. doi: 10.1371/journal.pone.0005862 PMID: 19517012;
PubMed Central PMCID: PMC2690690.
15. Cogliati M, Zamfirova RR, Tortorano AM, Viviani MA. Molecular epidemiology of Italian clinical Crypto-
coccus neoformans var. grubii isolates. Med Mycol. 2013; 51(5):499–506. doi: 10.3109/13693786.
2012.751642 PMID: 23286351
16. Kwon-Chung KJ, Boekhout T, Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii
against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae).
Taxon. 2002; 51(4):804–6.
17. Bovers M, Hagen F, Kuramae EE, Diaz MR, Spanjaard L, Dromer F, et al. Unique hybrids between the
fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res. 2006; 6
(4):599–607. Epub 2006/05/16. doi: 10.1111/j.1567-1364.2006.00082.x PMID: 16696655.
18. Bovers M, Hagen F, Kuramae EE, Hoogveld HL, Dromer F, St-Germain G, et al. AIDS patient death
caused by novel Cryptococcus neoformans × C. gattii hybrid. Emerg Infect Dis. 2008; 14(7):1105–8.
doi: 10.3201/eid1407.080122 PMID: 18598632
19. Aminnejad M, Diaz M, Arabatzis M, Castaneda E, Lazera M, Velegraki A, et al. Identification of novel
hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII. Mycopatholo-
gia. 2012; 173(5–6):337–46. Epub 2011/11/15. doi: 10.1007/s11046-011-9491-x PMID: 22081254.
20. Lin X, Heitman J. The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol.
2006; 60:69–105. doi: 10.1146/annurev.micro.60.080805.142102 PMID: 16704346
21. Currie B, Casadevall A. Estimation of the prevalence of Cryptococcal infection among patients infected
with the human immunodeficiency virus in New York City. Clin Infect Dis. 1994; 19:1029–33. PMID:
7888529
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 24 / 28
22. Franzot S, Hamdan J, Currie B, Casadevall A. Molecular epidemiology of Cryptococcus neoformans in
Brazil and the United States: evidence for both local genetic differences and a global clonal population
structure. J Clin Microbiol. 1997; 35:2243–51. PMID: 9276395
23. Viviani MA, Cogliati M, Esposto MC, Lemmer K, Tintelnot K, Valiente MFC, et al. Molecular analysis of
311 Cryptococcus neoformans isolates from a 30 month ECMM survey of cryptococcosis in Europe.
FEMS Yeast Res. 2006; 6(4):614–9. doi: 10.1111/j.1567-1364.2006.00081.x PMID: 16696657
24. Kwon-Chung K, Bennett JE. Distribution of and mating types of Cryptococcus neoformans among nat-
ural and clinical isolates. Am J Epidemiol. 1978; 108(4):337–40.
25. Lin X, Litvintseva AP, Nielsen K, Patel S, Floyd A, Mitchell TG, et al. αADα hybrids of Cryptococcus
neoformans: evidence of same-sex mating in nature and hybrid fitness. PLoS Genet. 2007; 3(10):
e186. doi: 10.1371/journal.pgen.0030186 PMID: 17953489
26. Lin X, Patel S, Litvintseva AP, Floyd A, Mitchell TG, Heitman J. Diploids in the Cryptococcus neofor-
mans serotype A population homozygous for the alpha mating type originate via unisexual mating.
PLoS Pathog. 2009; 5(1):e1000283. Epub 2009/01/31. doi: 10.1371/journal.ppat.1000283 PMID:
19180236; PubMed Central PMCID: PMC2629120.
27. Bovers M, Hagen F, Kuramae E, Boekhout T. Six monophyletic lineages identified within Cryptococcus
neoformans and Cryptococcus gattii by multi-locus sequence typing. Fungal Genet Biol. 2008; 45
(4):400–21. doi: 10.1016/j.fgb.2007.12.004 PMID: 18261945
28. Bui T, Lin X, Malik R, Heitman J, Carter D. Isolates of Cryptococcus neoformans from infected animals
reveal genetic exchange in unisexual, αmating type populations. Eukaryot Cell. 2008; 7(10):1771–80.
doi: 10.1128/EC.00097-08 PMID: 18552280
29. Hiremath SS, Chowdhary A, Kowshik T, Randhawa HS, Sun S, Xu J. Long-distance dispersal and
recombination in environmental populations of Cryptococcus neoformans var. grubii from India. Micro-
biology. 2008; 154(5):1513–24. doi: 10.1099/mic.0.2007/015594-0 PMID: 18451060
30. Saul N, Krockenberger M, Carter D. Evidence of recombination in mixed-mating-type and α-only popu-
lations of Cryptococcus gattii sourced from single Eucalyptus tree hollows. Eukaryot Cell. 2008; 7
(4):727–34. doi: 10.1128/EC.00020-08 PMID: 18281600
31. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, et al. Same-sex mating
and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature. 2005; 437(7063):1360–4.
Epub 2005/10/14. doi: 10.1038/nature04220 PMID: 16222245.
32. Litvintseva AP, Kestenbaum L, Vilgalys R, Mitchell TG. Comparative analysis of environmental and
clinical populations of Cryptococcus neoformans. J Clin Microbiol. 2005; 43(2):556–64. doi: 10.1128/
JCM.43.2.556-564.2005 PMID: 15695645
33. Cogliati M, Esposto MC, Tortorano AM, Viviani MA. Cryptococcus neoformans population includes
hybrid strains homozygous at mating-type locus. FEMS Yeast Res. 2006; 6(4):608–13. Epub 2006/05/
16. doi: 10.1111/j.1567-1364.2006.00085.x PMID: 16696656.
34. Chaturvedi V, Fan J, Stein B, Behr MJ, Samsonoff WA, Wickes BL, et al. Molecular genetic analyses
of mating pheromones reveal intervariety mating or hybridization in Cryptococcus neoformans. Infect
Immun. 2002; 70(9):5225–35. doi: 10.1128/IAI.70.9.5225-5235.2002 PMID: 12183574
35. Barchiesi F, Cogliati M, Esposto M, Spreghini E, Schimizzi A, Wickes B, et al. Comparative analysis of
pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. J Infect.
2005; 51(1):10–6. doi: 10.1016/j.jinf.2004.07.013 PMID: 15979484
36. Civetta ACA, Shahid MSM, Han SHS, Yoell HYH, Xu JXJ. Fitness distribution and transgressive segre-
gation across 40 environments in a hybrid progeny population of the human-pathogenic yeast Crypto-
coccus neoformans. Genome. 2008; 51(4):272–81. doi: 10.1139/G08-004 PMID: 18356963
37. Lin X, Nielsen K, Patel S, Heitman J. Impact of mating type, serotype, and ploidy on the virulence of
Cryptococcus neoformans. Infect Immun. 2008; 76(7):2923–38. doi: 10.1128/IAI.00168-08 PMID:
18426889
38. Cogliati M, Barchiesi F, Spreghini E, Tortorano AM. Heterozygosis and pathogenicity of Cryptococcus
neoformans AD-hybrid isolates. Mycopathologia. 2012; 137(5–6):347–57.
39. Franzot S, Salkin I, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for
Cryptococcus neoformans serotype A isolates. J Clin Microbiol. 1999; 37:838–40. PMID: 9986871
40. Viviani M, Esposto M, Cogliati M, Montagna M, Wickes B. Isolation of a Cryptococcus neoformans
serotype A MATa strain from the Italian environment. Med Mycol. 2001; 39(5):383–6. PMID: 12054047
41. Kwon-Chung KJ, Edman J, Wickes BII. Genetic association of mating types and virulence in Crypto-
coccus neoformans. Infect Immun. 1992; 60:602–5. PMID: 1730495
42. Sanfelice F. Contributo alla morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni
frutti. Ann Ig. 1894; 4:463–95.
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 25 / 28
43. Fraser JA, Subaran RL, Nichols CB, Heitman J. Recapitulation of the sexual cycle of the primary fungal
pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Can-
ada. Eukaryot Cell. 2003; 2(5):1036–45. doi: 10.1128/EC.2.5.1036-1045.2003 PMID: 14555486
44. Kidd S, Hagen F, Tscharke R, Huynh M, Bartlett K, Fyfe M, et al. A rare genotype of Cryptococcus gattii
caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad
Sci U S A. 2004; 101(49):17258–63. doi: 10.1073/pnas.0402981101 PMID: 15572442
45. Ferrer C, Colom F, Frases S, Mulet E, Abad JL, Alio JL. Detection and identification of fungal patho-
gens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J Clin Microbiol. 2001;
39(8):2873–9. Epub 2001/07/28. doi: 10.1128/JCM.39.8.2873-2879.2001 PMID: 11474006; PubMed
Central PMCID: PMC88253.
46. Diaz MR, Fell JW. Use of a suspension array for rapid identification of the varieties and genotypes of
the Cryptococcus neoformans species complex. J Clin Microbiol. 2005; 43(8):3662–72. Epub 2005/08/
06. doi: 10.1128/JCM.43.8.3662-3672.2005 PMID: 16081894; PubMed Central PMCID:
PMC1233893.
47. Diaz MR, Dunbar SA, Jacobson JW. Multiplexed detection of fungal nucleic acid signatures. In: Robin-
son J, Darzynkiewicz Z, Hoffman R, Nolan J, Rabinovitch P, Watkins S, editors. Current Protocols in
Cytometry. 44. New York, NY: Wiley; 2008. p. 13.9.1–.9.21.
48. Dien B, Peterson M, Srienc F. Cell cycle analysis in Saccharomyces cerevisiae. In: Darzynkiewicz Z,
Robinson J, Crissman H, editors. Methods Cell Biol. 42. USA: Academic Press; 1994. p. 457–75.
PMID: 7533252
49. Chaturvedi S, Rodeghier B, Fan J, McClelland C, Wickes B, Chaturvedi V. Direct PCR of Cryptococcus
neoformans MATα and MATa pheromones to determine mating type, ploidy, and variety: a tool for epi-
demiological and molecular pathogenesis studies. J Clin Microbiol. 2000; 38:2007–9. PMID: 10790143
50. Enache-Angoulvant A, Chandenier J, Symoens F, Lacube P, Bolognini J, Douchet C, et al. Molecular
identification of Cryptococcus neoformans serotypes. J Clin Microbiol. 2007; 45(4):1261–5. Epub
2007/02/09. doi: 10.1128/JCM.01839-06 PMID: 17287323; PubMed Central PMCID: PMC1865818.
51. Esposto M, Cogliati M, Tortorano A, Viviani M. Determination of Cryptococcus neoformans var. neofor-
mans mating type by multiplex PCR. Clin Microbiol Infect. 2004; 10(12):1092–4. doi: 10.1111/j.1469-
0691.2004.00972.x PMID: 15606637
52. Eisentraut. SOP for sample preperation using formic acid extraction method. Bruker Daltonics.
2009:1–2.
53. Firacative C, Trilles L, Meyer W. MALDI-TOF MS enables the rapid identification of the major molecu-
lar types within the Cryptococcus neoformans/C. gattii Species Complex. PLoS One. 2012; 7(5):
e37566. doi: 10.1371/journal.pone.0037566 PMID: 22666368
54. Cotter G, Doyle S, Kavanagh K. Development of an insect model for the in vivo pathogenicity testing of
yeasts. FEMS Immunol Med Microbiol. 2000; 27(2):163–9. PMID: 10640612
55. Chaskes S, Tyndall RL. Pigment production by Cryptococcus neoformans from para-and ortho-Diphe-
nols: effect of the nitrogen source. J Clin Microbiol. 1975; 1(6):509–14. PMID: 1100669
56. Missall TA, Moran JM, Corbett JA, Lodge JK. Distinct stress responses of two functional laccases in
Cryptococcus neoformans are revealed in the absence of the thiol-specific antioxidant Tsa1. Eukaryot
Cell. 2005; 4(1):202–8. doi: 10.1128/EC.4.1.202-208.2005 PMID: 15643075
57. Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. Regulation of capsule
synthesis by carbon dioxide. J Clin Invest. 1985; 76(2):508–16. doi: 10.1172/JCI112000 PMID:
3928681
58. Zaragoza O, Fries BC, Casadevall A. Induction of capsule growth in Cryptococcus neoformans by
mammalian serum and CO2. Infect Immun. 2003; 71(11):6155–64. doi: 10.1128/IAI.71.11.6155-6164.
2003 PMID: 14573631
59. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida
albicans. Med Mycol. 1982; 20(1):7–14.
60. CLSI. Reference methods for broth dilution antifungal susceptibility testing of yeast; approved stan-
dard. Third ed. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2008.
61. Chen SCA, Brownlee AG, Sorrell TC, Ruma P, Ellis DH, Pfeiffer T, et al. Identification by random
amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neo-
formans in patients with AIDS or other immunosuppressive conditions. J Infect Dis. 1996; 173(3):754–
7. doi: 10.1093/infdis/173.3.754 PMID: 8627047
62. Lemmer K, Naumann D, Raddatz B, Tintelnot K. Molecular typing of Cryptococcus neoformans by
PCR fingerprinting, in comparison with serotyping and Fourier transform infrared-spectroscopy-based
phenotyping. Med Mycol. 2004; 42(2):135–47. PMID: 15124867
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 26 / 28
63. Perfect J, Ketabchi N, Cox G, Ingram C, Beiser C. Karyotyping of Cryptococcus neoformans as an epi-
demiological tool. J Clin Microbiol. 1993; 31(12):3305–9. PMID: 8308124
64. Boekhout T, Theelen B, Diaz M, Fell JW, Hop WCJ, Abeln ECA, et al. Hybrid genotypes in the patho-
genic yeast Cryptococcus neoformans. Microbiology. 2001; 147(4):891–907.
65. Espinel-Ingroff A, Aller A, Canton E, Castaño´n-Olivares L, Chowdhary A, Cordoba S, et al. Cryptococ-
cus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility
endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole
and voriconazole. Antimicrob Agents Chemother. 2012:AAC. 01115–12.
66. Litvintseva AP, Lin X, Templeton I, Heitman J, Mitchell TG. Many globally isolated AD hybrid strains of
Cryptococcus neoformans originated in Africa. PLoS Pathog. 2007; 3(8):e114. doi: 10.1371/journal.
ppat.0030114 PMID: 17708680
67. Xu J, Vilgalys R, Mitchell TG. Multiple gene genealogies reveal recent dispersion and hybridization in
the human pathogenic fungus Cryptococcus neoformans. Mol Ecol. 2000; 9(10):1471–81. PMID:
11050543
68. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS, Casadevall A. Microevolution of a stan-
dard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
Infect Immun. 1998; 66(1):89–97. PMID: 9423844
69. McTaggart LR, Lei E, Richardson SE, Hoang L, Fothergill A, Zhang SX. Rapid Identification of Crypto-
coccus neoformans and Cryptococcus gattii by Matrix-Assisted Laser Desorption Ionization—Time of
Flight Mass Spectrometry. J Clin Microbiol. 2011; 49(8):3050–3. doi: 10.1128/JCM.00651-11 PMID:
21653762
70. Posteraro B, Vella A, Cogliati M, De Carolis E, Florio AR, Posteraro P, et al. Matrix-assisted laser
desorption ionization—time of flight mass spectrometry-based method for discrimination between
molecular types of Cryptococcus neoformans and Cryptococcus gattii. J Clin Microbiol. 2012; 50
(7):2472–6. doi: 10.1128/JCM.00737-12 PMID: 22573595
71. Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, et al. Galleria mellonella
as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun. 2005; 73
(7):3842–50. doi: 10.1128/IAI.73.7.3842-3850.2005 PMID: 15972469
72. Bergin D, Reeves E, Renwick J, Wientjes F, Kavanagh K. Superoxide production in Galleria mellonella
hemocytes: identification of proteins homologous to the NADPH oxidase complex of human neutro-
phils. Infect Immun. 2005; 73(7):4161–70. doi: 10.1128/IAI.73.7.4161-4170.2005 PMID: 15972506
73. Fuchs BB, O’Brien E, El Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model
host to study fungal pathogenesis. Virulence. 2010; 1(6):475–82. PMID: 21178491
74. Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albi-
cans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol. 2006; 34(2):153–
7.
75. Reeves EP, Messina C, Doyle S, Kavanagh K. Correlation between gliotoxin production and virulence
of Aspergillus fumigatus in Galleria mellonella. Mycopathologia. 2004; 158(1):73–9. PMID: 15487324
76. St Leger RJ, Screen SE, Shams-Pirzadeh B. Lack of Host Specialization in Aspergillus flavus. Appl
Environ Microbiol. 2000; 66(1):320–4. PMID: 10618242
77. Lengeler KB, Wang P, Cox GM, Perfect JR, Heitman J. Identification of the MATa mating-type locus of
Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct. Proc Natl
Acad Sci U S A. 2000; 97(26):14455–60. doi: 10.1073/pnas.97.26.14455 PMID: 11121047
78. Keller S, Viviani M, Esposto M, Cogliati M, Wickes B. Molecular and genetic characterization of a sero-
type A MATa Cryptococcus neoformans isolate. Microbiology. 2003; 149(1):131–42.
79. Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neofor-
mans during murine pulmonary infection. Microbiology. 2001; 147(8):2355–65.
80. Zaragoza O, Garcı´a-Rodas R, Nosanchuk JD, Cuenca-Estrella M, Rodrı´guez-Tudela JL, Casadevall
A. Fungal cell gigantism during mammalian infection. PLoS Pathog. 2010; 6(6):e1000945. doi: 10.
1371/journal.ppat.1000945 PMID: 20585557
81. Garcı´a-Rodas R, Casadevall A, Rodrı´guez-Tudela JL, Cuenca-Estrella M, Zaragoza O. Cryptococcus
neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS
One. 2011; 6(9):e24485. doi: 10.1371/journal.pone.0024485 PMID: 21915338
82. Okagaki LH, Strain AK, Nielsen JN, Charlier C, Baltes NJ, Chre´tien F, et al. Cryptococcal cell morphol-
ogy affects host cell interactions and pathogenicity. PLoS Pathog. 2010; 6(6):e1000953. doi: 10.1371/
journal.ppat.1000953 PMID: 20585559
83. Chen SCA, Muller M, Zhou JZ, Wright LC, Sorrell TC. Phospholipase activity in Cryptococcus neofor-
mans: a new virulence factor? J Infect Dis. 1997; 175(2):414–20. PMID: 9203663
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 27 / 28
84. Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E, Klaassen CH, et al. In vitro antifungal
susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of
350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother.
2010; 54(12):5139–45. Epub 2010/09/22. doi: 10.1128/AAC.00746-10 PMID: 20855729; PubMed
Central PMCID: PMC2981230.
85. Trilles L, Fernandez-Torres B, dos Santos Lazera M, Wanke B, Guarro J. In vitro antifungal susceptibil-
ity of Cryptococcus gattii. J Clin Microbiol. 2004; 42(10):4815–7. doi: 10.1128/JCM.42.10.4815-4817.
2004 PMID: 15472349
86. Thompson GR 3rd, Wiederhold NP, Fothergill AW, Vallor AC, Wickes BL, Patterson TF. Antifungal
susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans. Anti-
microb Agents Chemother. 2009; 53(1):309–11. Epub 2008/10/29. doi: 10.1128/AAC.01216-08 PMID:
18955539; PubMed Central PMCID: PMC2612192.
87. Iqbal N, DeBess EE, Wohrle R, Sun B, Nett RJ, Ahlquist AM, et al. Correlation of genotype and in vitro
susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin
Microbiol. 2010; 48(2):539–44. Epub 2009/12/17. doi: 10.1128/JCM.01505-09 PMID: 20007380;
PubMed Central PMCID: PMC2815610.
88. Chong HS, Dagg R, Malik R, Chen S, Carter D. In vitro susceptibility of the yeast pathogen Cryptococ-
cus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol. 2010; 48
(11):4115–20. doi: 10.1128/JCM.01271-10 PMID: 20844209
89. Trilles L, Meyer W, Wanke B, Guarro J, Laze´ra M. Correlation of antifungal susceptibility and molecular
type within the Cryptococcus neoformans/C. gattii species complex. Med Mycol. 2012; 50(3):328–32.
doi: 10.3109/13693786.2011.602126 PMID: 21859388
Identification and Characterization of Cryptococcal Hybrids
PLOS ONE | DOI:10.1371/journal.pone.0163955 October 20, 2016 28 / 28
